Sort   by:  
 Page size 
UnknownAnalysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study.
Not available
S-EPMC5888948 | biostudies-literature
UnknownFour-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial.
Not available
S-EPMC10862253 | biostudies-literature
UnknownFirst-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update.
Not available
S-EPMC8493593 | biostudies-literature
UnknownNeoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
Not available
S-EPMC9844511 | biostudies-literature
UnknownFirst-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
Not available
S-EPMC6487310 | biostudies-literature
Sort   by:  
 Page size